Literature DB >> 9596659

NF-kappaB transcription factors are involved in normal erythropoiesis.

M Y Zhang1, S C Sun, L Bell, B A Miller.   

Abstract

NF-kappaB/Rel designates a widely distributed family of transcription factors involved in immune and acute phase responses. Here, the expression and function of NF-kappaB factors in erythroid proliferation and differentiation were explored. In an erythroleukemia cell line, TF-1, high levels of p105/p50, p100/p52, p65, and IkappaBalpha were detected 24 hours after growth factor deprivation. In response to granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation, significant induction of p52 expression was observed. GM-CSF also induced nuclear translocation of both p52 and p65. No induction of NF-kappaB factors was observed with erythropoietin stimulation of TF-1 cells. Overexpression of p52 and p65 in TF-1 cells by transient transfection resulted in significant induction of a kappaB-TATA-luciferase reporter plasmid, showing that these factors are functional in vivo in erythroid cells. To determine whether NF-kappaB factors may play a role in normal erythropoiesis, levels of these factors were determined in burst-forming unit-erythroid (BFU-E)-derived cells at different stages of differentiation. The NF-kappaB factors p105/p50, p100/p52, and p65 were highly expressed in early BFU-E-derived precursors, which are rapidly proliferating, and declined during maturation. Furthermore, nuclear levels of NF-kappaB factors p50, p52, and p65 were higher in less mature precursors (day 10 BFU-E-derived cells) compared with more differentiated (day 14) erythroblasts. In nuclear extracts from day 10 BFU-E-derived cells, p50, p52, and p65 were able to form complexes, which bound to kappaB sites in the promoters of both the c-myb and c-myc genes, suggesting that c-myb and c-myc may be among the kappaB-containing genes regulated by NF-kappaB factors in normal erythroid cells. Taken together, these data show that NF-kappaB factors are modulated by GM-CSF and suggest they function to regulate specific kappaB containing genes involved in erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596659

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.

Authors:  Nayan J Sarma; Nabeel R Yaseen
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia.

Authors:  Sophia E Maharry; Christopher J Walker; Sandya Liyanarachchi; Sujay Mehta; Mitra Patel; Maryam A Bainazar; Xiaomeng Huang; Malori A Lankenau; Kevin W Hoag; Parvathi Ranganathan; Ramiro Garzon; James S Blachly; Denis C Guttridge; Clara D Bloomfield; Albert de la Chapelle; Ann-Kathrin Eisfeld
Journal:  Cancer Discov       Date:  2016-06-27       Impact factor: 39.397

3.  B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR.

Authors:  Stephanie C Casey; Edward L Nelson; Gina M Turco; Matthew R Janes; David A Fruman; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2011-03-24

4.  Resveratrol ameliorates TNFα-mediated suppression of erythropoiesis in human CD34(+) cells via modulation of NF-κB signalling.

Authors:  Jee-Yeong Jeong; Matthew Silver; Aric Parnes; Sarah Nikiforow; Nancy Berliner; Gary J Vanasse
Journal:  Br J Haematol       Date:  2011-07-18       Impact factor: 6.998

5.  Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells.

Authors:  T Shingo; S T Sorokan; T Shimazaki; S Weiss
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

6.  Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.

Authors:  Lucy A McNamara; Janani A Ganesh; Kathleen L Collins
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

7.  Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.

Authors:  Agnès Coste; Maria Cristina Antal; Susan Chan; Philippe Kastner; Manuel Mark; Bert W O'Malley; Johan Auwerx
Journal:  EMBO J       Date:  2006-05-04       Impact factor: 11.598

8.  Development of B cells and erythrocytes is specifically impaired by the drug celastrol in mice.

Authors:  Sophie Kusy; Eliver E B Ghosn; Leonore A Herzenberg; Christopher H Contag
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

9.  The NF-κB p65/miR-23a-27a-24 cluster is a target for leukemia treatment.

Authors:  Yong-Chang Zhang; Hui Ye; Zhi Zeng; Y Eugene Chin; Yu-Ning Huang; Guo-Hui Fu
Journal:  Oncotarget       Date:  2015-10-20

10.  Detection of a functional hybrid receptor gammac/GM-CSFRbeta in human hematopoietic CD34+ cells.

Authors:  J Giron-Michel; M Fogli; A Gaggero; S Ferrini; A Caignard; D Brouty-Boye; S Baouz; M-C Le Bousse-Kerdiles; B Peault; M van Dijk; S Bulfone-Paus; D Durali; S Chouaib; B Azzarone
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.